Identification of GLA/SE as an effective adjuvant for the induction of robust humoral and cell-mediated immune responses to EBV-gp350 in mice and rabbits.

Heeke, Darren S; Lin, Rui; Rao, Eileen; Woo, Jennifer C; McCarthy, Michael P; Marshall, Jason D

Heeke, Darren S; Lin, Rui; Rao, Eileen; Woo, Jennifer C; McCarthy, Michael P; Marshall, Jason D.

Affiliation

Heeke DS; Applied Immunology and Microbiology Group, MedImmune, Mountain View, CA, USA.
Lin R; Applied Immunology and Microbiology Group, MedImmune, Mountain View, CA, USA.
Rao E; Translational Biology Group, MedImmune, Mountain View, CA, USA.
Woo JC; Translational Biology Group, MedImmune, Mountain View, CA, USA.
McCarthy MP; Vaccine Platform Group, MedImmune, Gaithersburg, MD, USA.
Marshall JD; Vaccine Platform Group, MedImmune, Gaithersburg, MD, USA. Electronic address: marshallj@medimmune.com.

Vaccine ; 34(23): 2562-9, 2016 05 17.

Article de En | MEDLINE | ID: mdl-27085175

Sujet(s)
Mots clés

Adjuvants; EpsteinBarr virus; GLA; Gp350; Infectious mononucleosis

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccins antiviraux / Protéines de la matrice virale / Adjuvants immunologiques / Immunité humorale / Immunité cellulaire Type d'étude: Diagnostic_studies Limites: Animals Langue: En Journal: Vaccine Année: 2016 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Pays-Bas

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google